This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Johannes Gutenberg-Universität Mainz. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Simone Thomas: Innovator in Genetic Constructs
Introduction
Simone Thomas is a prominent inventor based in Mainz, Germany. She has made significant contributions to the field of genetic engineering, particularly in the development of single-chain antigen-recognizing genetic constructs. Her innovative work has the potential to advance therapeutic approaches in cancer treatment.
Latest Patents
Simone Thomas holds a patent titled "Method for improving the specific effector function of single-chain antigen-recognizing genetic constructs (scARC) through murinization thereof." This invention relates to a method for producing a cell line that expresses a stabilized functional single-chain antigen-recognizing genetic construct. The method involves co-expression of genetic constructs that contain human and murine amino acid exchanges, which can enhance the efficacy of T-cell responses against tumor-associated peptide antigens.
Career Highlights
Simone Thomas is affiliated with Johannes Gutenberg-Universität Mainz, where she conducts her research and development. Her work has garnered attention for its innovative approach to improving T-cell receptor functionality, which is crucial for targeted cancer therapies.
Collaborations
Throughout her career, Simone has collaborated with notable colleagues, including Ralf-Holger Voss and Matthias Theobald. These collaborations have further enriched her research and contributed to advancements in the field.
Conclusion
Simone Thomas is a trailblazer in the realm of genetic constructs, with her patent showcasing her innovative spirit and dedication to improving cancer therapies. Her contributions are paving the way for future advancements in medical science.